The need for a formal invalidation process for animal and non-animal tests

Alternatives to Laboratory Animals

Volumn 33, Issue 3, 2005, Pages 299-308

  Balls, Michael ^a   Combes, Robert ^a  

^a RUSSELL AND BURCH HOUSE   (United Kingdom)

Author keywords

Animal tests; ECVAM; ICCVAM; In vitro tests; Invalidation; OECD; Test development; Uterotrophic assay; Validation

Indexed keywords

CHEMICAL AGENT;

ANIMAL TESTING ALTERNATIVE; ANIMAL TESTING REPLACEMENT; ANIMAL WELFARE; ASSAY; CHEMICAL ANALYSIS; IN VITRO STUDY; METHODOLOGY; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; TOXICITY TESTING; VALIDATION PROCESS;

ANIMALIA;

EID: 21844460035     PISSN: 02611929     EISSN: None     Source Type: Journal    
DOI: 10.1177/026119290503300301     Document Type: Review

References (29)

1. Balls, M., Blaauboer, B., Brusick, D., Frazier, J., Lamb, D., Pemberton, M., Reinhardt, C., Roberfroid, M., Rosenkranz, H., Schmid, B., Spielmann, H., Stammati, A-L. & Walum, E. (1990). Report and recommendations of the CAAT/ERGATT workshop on the validation of toxicity test procedures. ATLA 18, 313-337.
2. Balls, M., Botham, P.A., Bruner, L.H. & Spielmann, H. (1995). The EC/HO international validation study on alternatives to the Draize eye irritation test. Toxicology in Vitro 9, 871-929.
3. Balls, M., Blaauboer, B.J., Fentem, J.H., Bruner, L., Combes, R.D., Ekwall, B., Fielder, R.J., Guillouzo, A., Lewis, R.W., Lovell, D.P., Reinhardt, C.A., Repetto, G., Sladowski, D., Spielmann, H. & Zucco, F. (1995). Practical aspects of the validation of toxicity test procedures. The report and recommendations of ECVAM workshop 5. ATLA 23, 129-147.
4. Bruner, L.H., Carr, G. J., Chamberlain, M. & Gurren, R.D. (1996). Validation of alternative methods for toxicity testing. Toxicology in Vitro 10, 479-501.
5. Curren, R.D., Southee, J.A., Spielmann, H., Liebsch, M., Fentem, J.H. & Balls, M. (1995). The role of prevalidation in the development, validation and acceptance of alternative methods. ATLA 23, 211-217.
6. Balls, M. & Karcher, W. (1995). The validation of alternative test methods. ATLA 23, 884-886.
7. NIH (1997). Validation and Regulatory Acceptance of Toxicological Test Methods: A Report of the ad hoc Interagency Coordinating Committee on the Validation of Alternative Methods. NIH Publication No. 97-398. 105pp. Research Triangle Park, NC, USA: NIEHS.
8. OECD (1996). Final Report of the OECD Workshop on Harmonization of Validation and Acceptance Criteria for Alternative Toxicological Test Methods. 60pp. Paris, France: OECD.
9. Balls, M. (2002). The establishment of ECVAM and its progress since 1993. ATLA 30, Suppl. 2, 3-11.
10. Worth, A.P. & Balls, M. (2001). The role of ECVAM in promoting the regulatory acceptance of alternative methods in the European Union. ATLA 29, 525-535.
11. Worth, A.P. & Balls, M. (2002). The principles of validation and the ECVAM validation process. ATLA 30, Suppl. 2, 15-21.
12. Combes, R.D. & Balls, M. (2003). How much flexibility is possible when validating new in vivo and in vitro toxicity test methods? ATLA 31, 225-232.
13. Archer, G., Balls, M., Bruner, L.H., Curren, R.D., Fentem, J.H., Holzhütter, H-G., Liebsch, M., Lovell, D.P. & Southee, J.A. (1997). The validation of toxicological prediction models. ATLA 25, 505-516.
14. Worth, A.P. & Balls, M. (2001). The importance of the prediction model in the development and validation of alternative tests. ATLA 29, 135-143.
15. O'Connor, A.M. (1997). Barriers to regulatory acceptance. In: Animal Alternatives, Welfare' and Ethics (ed. L.F.M. van Zutphen & M. Balls), pp. 1173-1176. Amsterdam, The Netherlands: Elsevier Science B.V.
16. Balls, M. (2004). Are animal tests inherently valid? ATLA 32, Suppl. 1B, 755-758.
17. Balls, M. (1997). Defined structural and performance criteria would facilitate the validation and acceptance of alternative test procedures. ATLA 25, 483-484.
18. Liebsch, M., Traue, D., Barrabas, C., Spielmann, H., Uphill, P., Wilksins, S., McPherson, J.P., Wiemann, C., Kaufmann, T., Remmele, M. & Holzhütter, H-G. (2000). The ECVAM prevalidation study on the use of EpiDerm for skin corrosivity testing. ATLA 28, 371-401.
19. OECD (2002). OECD Guidelines for the Testing of Chemicals No. 431. In Vitro Skin Corrosion: Human Skin Model Test. 8pp. Paris, France: OECD.
20. Combes, R.D. (2000). Endocrine disruptors: a critical review of in vitro and in vivo testing strategies for assessing their toxic hazard to humans. ATLA 28, 81-118.
21. Combes, R.D., Gaunt, I. & Balls, M. (2004). A scientific and animal welfare assessment of the OECD Health Effects Test Guidelines for the safety testing of chemicals under the European Union REACH system. ATLA 32, 163-208.
22. Clemedson, C. & Ekwall, B. (1999). Overview of the final MEIC results: I. The in vitro-in vivo evaluation. Toxicology in Vitro 13, 657-663.
23. Ekwall, B. (1999). Overview of the final MEIC results: II. The in vitro-in vivo evaluation, including the selection of a practical battery of cell tests for prediction of acute lethal blood concentrations in humans. Toxicology in Vitro 13, 665-673.
24. Anon. (2004). Report for Establishing the Timetable for Phasing Out Animal Testing for the Purpose of the Cosmetic Directive. Brussels, Belgium: Unit F3 - Cosmetics and Medical Devices, DG Enterprise and Industry, European Commission. Website http://pharmacos.eudra.org/F3/cosmetic/AnimalTest.htm (Accessed on 27.5.05).
25. Eskes, C. & Zuang, V. ed. (2005). Alternative (Non-Animal) Methods for Cosmetics Testing: Current Status and Future Prospects. ATLA 33, Suppl. 1, in press.
26. Combes, R.D. (2003). A critical assessment of the OECD collaborative study to validate the uterotrophic assay for the detection of oestrogenic and anti-oestrogenic chemicals. ATLA 31, 489-499.
27. Combes, R.D. (2004). Peer review of validation studies: an assessment of the role of the OECD by reference to the validation of the uterotrophic assay for endocrine disruptors. ATLA 32, 111-117.
28. Anon. (2004). General Guidelines for Submitting a Proposal to ECVAM for the Evaluation of the Readiness of a Test Method to Enter the ECVAM Prevalidation and/or Validation Process. 10pp. Ispra, Italy: ECVAM, Institute for Health & Consumer Protection, EC Joint Research Centre. Website www.ecvam.jrc.cec.eu.int (Accessed on 27.5.05).
29. Stokes, W.S., Schechtman, L.M. & Hill, R.N. (2002). The Interagency Coordinating Committee on the Validation of Alternative Methods (ICCVAM): a review of the ICCVAM test method evaluation process and current international collaborations with the European Centre for the Validation of Alternative Methods (ECVAM). ATLA 30, Suppl. 2, 23-32.